Gregory Zuckerman examines the global race between Oxford-AstraZeneca, Pfizer-BioNTech, and J&J, emphasizing the different scientific approaches and the logistical advantages of one-shot vaccines. 6
Season 8, Episode 493, Feb 22, 03:26 AM
We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.
Please check your internet connection and refresh the page. You might also try disabling any ad blockers.
You can visit our support center if you're having problems.